ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $36,000 | -73.1% | 2,325 | -61.1% | 0.02% | -60.5% |
| Q1 2018 | $134,000 | -22.1% | 5,977 | +4.4% | 0.04% | -24.0% |
| Q4 2017 | $172,000 | +3.0% | 5,727 | +29.4% | 0.05% | -10.7% |
| Q3 2017 | $167,000 | +33.6% | 4,427 | -1.2% | 0.06% | +24.4% |
| Q2 2017 | $125,000 | +81.2% | 4,479 | +60.5% | 0.04% | +28.6% |
| Q3 2014 | $69,000 | +72.5% | 2,790 | +59.4% | 0.04% | +84.2% |
| Q2 2014 | $40,000 | +471.4% | 1,750 | +483.3% | 0.02% | +850.0% |
| Q1 2014 | $7,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $7,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |